SemiLEDs Reports Third Quarter Fiscal Year 2017 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
88
SemiLEDs Reports Third Quarter Fiscal Year 2017 Financial Results

HSINCHU, Taiwan, July 12, 2017 (GLOBE NEWSWIRE) -- SemiLEDs Corporation (NASDAQ: LEDS ), “SemiLEDs” or the “Company,” a developer and manufacturer of LED chips and LED components, today announced its financial results for the third quarter of fiscal year 2017, ended May 31, 2017.

Revenue for the third quarter of fiscal 2017 was $2.1 million, a 15% increase compared to $1.8 million in the second quarter of fiscal 2017. GAAP net loss attributable to SemiLEDs stockholders for the third quarter of fiscal 2017 was $1.6 million, or a net loss of $0.45 per diluted share, compared to a loss of $1.1 million, or a net loss of $0.32 per diluted share for the second quarter of fiscal 2017. The GAAP net loss of $1.6 million for the third quarter of fiscal 2017 included impairment loss of $352 thousand pertained to cost method investment.

On a non-GAAP basis, net loss attributable to SemiLEDs stockholders for the third quarter of fiscal 2017 was $1.2 million, or a net loss of $0.34 per diluted share, compared to non-GAAP net loss attributable to SemiLEDs stockholders of $1.1 million, or a net loss of $0.30 in the second quarter of 2017.

GAAP gross margin for the third quarter of fiscal 2017 was negative 9%, compared with gross margin for the second quarter of fiscal 2017 of breakeven. Operating margin for the third quarter of fiscal 2017 was negative 61%, compared with negative 62% in the second quarter of fiscal 2017. The Company’s cash and cash equivalents was $3.1 million at May 31, 2017, compared to $4.1 million at the end of the second quarter of fiscal 2017. Cash used in operating activities was $0.9 million in the third quarter of fiscal 2017, compared with $0.6 million in the second quarter of fiscal 2017.

We expect revenue for the fourth quarter ending August 31, 2017 to be approximately $2.2 million +/- 10%.

About SemiLEDs

SemiLEDs develops and manufactures LED chips and LED components primarily for general lighting applications, including street lights and commercial, industrial and residential lighting, along with specialty industrial applications such as ultraviolet (UV) curing, medical/cosmetic, counterfeit detection, horticulture, architectural lighting and entertainment lighting. SemiLEDs sells blue, white, green and UV LED chips.

Non-GAAP Financial Measures

SemiLEDs has provided in this press release adjusted financial measures that has not been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP. SemiLEDs uses these non-GAAP financial measures internally in analyzing its financial results and believes they are useful to investors, as a supplement to, but not as a substitute for, GAAP measures, in evaluating the Company’s operational performance. SemiLEDs believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating operating results and trends, and in comparing its financial results with other companies in SemiLEDs’ industry, many of which present similar non-GAAP financial measures to investors. The historical non-GAAP financial measures presented above exclude the following items required to be included by GAAP: non-cash stock-based compensation charges, non-cash impairment charges on investment and the related tax effect, if any. In addition to the non-GAAP financial measures discussed above, SemiLEDs also uses free cash flow as a measure of operating performance. Free cash flow represents cash provided by operating activities less capital expenditures.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of historic non-GAAP financial measures to GAAP results has been provided in the financial statement tables included in this press release.

Forward Looking Statements

This press release contains statements that may constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, any projection of future revenues, any statements about historical results that may suggest trends for SemiLEDs’ business; any statements of the plans, strategies and objectives of management for future operations; any statements of expectation or belief regarding recovery of the LED industry, market opportunities and other future events or technology developments; any statements regarding SemiLEDs’ position to capitalize on any market opportunities; and any statements of assumptions underlying any of the foregoing. These forward-looking statements are based on current expectations, estimates, forecasts and projections of future SemiLEDs’ or industry performance based on management’s judgment, beliefs, current trends and market conditions and involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. SemiLEDs’ Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) and other SemiLEDs filings with the SEC (which you may obtain for free at the SEC’s website at http://www.sec.gov) discuss some of the important risks and other factors that may affect SemiLEDs’ business, results of operations and financial condition. SemiLEDs undertakes no intent or obligation to publicly update or revise any of these forward looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Source: SemiLEDs Corporation

     
SEMILEDS CORPORATION AND SUBSIDIARIES Unaudited Condensed Consolidated Balance Sheets (In thousands of U.S. dollars)    
               
    May 31,     February 28,    
    2017     2017    
ASSETS                  
CURRENT ASSETS:                  
Cash and cash equivalents   $ 3,137     $ 4,068    
Accounts receivable (including related parties), net     1,277       1,075    
Inventories     3,369       3,782    
Prepaid expenses and other current assets     537       589    
Total current assets     8,320       9,514    
Property, plant and equipment, net     8,558       8,588    
Intangible assets, net     63       63    
Investments in unconsolidated entities     995       1,330    
Other assets     361       368    
TOTAL ASSETS   $ 18,297     $ 19,863    
LIABILITIES AND EQUITY                  
CURRENT LIABILITIES:                  
Current installments of long-term debt   $ 335     $ 327    
Accounts payable     837       1,079    
Advance receipt toward the convertible note     500       500    
Accrued expenses and other current liabilities     5,437       5,242    
Total current liabilities     7,109       7,148    
Long-term debt, excluding current installments     2,484       2,521    
Total liabilities     9,593       9,669    
Commitments and contingencies                  
EQUITY:                  
SemiLEDs stockholders’ equity                  
Common stock     —       —    
Additional paid-in capital     175,568       175,548    
Accumulated other comprehensive income     3,733       3,634    
Accumulated deficit     (170,597 )     (169,011 )  
Total SemiLEDs stockholders’ equity     8,704       10,171    
Noncontrolling interests     —       23    
Total equity     8,704       10,194    
TOTAL LIABILITIES AND EQUITY   $ 18,297     $ 19,863    
SEMILEDS CORPORATION AND SUBSIDIARIES Unaudited Condensed Consolidated Statements of Operations (In thousands of U.S. dollars and shares, except per share data)    
     
    Three  Months  Ended    
    May 31,     February 28,    
    2017     2017    
Revenues, net   $ 2,111     $ 1,830    
Cost of revenues     2,297       1,823    
Gross profit (loss)     (186 )     7    
Operating expenses:                  
Research and development     257       195    
Selling, general and administrative     879       941    
Gain on disposals of long-lived assets     (33 )     —    
Total operating expenses     1,103       1,136    
Loss from operations     (1,289 )     (1,129 )  
Other income (expenses):                  
Impairment loss on investment     (352 )     —    
Equity in loss from unconsolidated entities     —       (2 )  
Interest expenses, net     (9 )     (8 )  
Other income, net     29       20    
Foreign currency transaction gain (loss), net     35       (30 )  
Total other income (expenses), net     (297 )     (20 )  
Loss before income taxes     (1,586 )     (1,149 )  
Income tax expense     —       —    
Net loss     (1,586 )     (1,149 )  
Less: Net loss attributable to noncontrolling interests     —       (7 )  
Net loss attributable to SemiLEDs stockholders   $ (1,586 )   $ (1,142 )  
Net loss per share attributable to SemiLEDs stockholders:                  
Basic and diluted   $ (0.45 )   $ (0.32 )  
Shares used in computing net loss per share attributable to SemiLEDs stockholders:                  
Basic and diluted     3,544       3,532    
SEMILEDS CORPORATION AND SUBSIDIARIES Unaudited Reconciliation of GAAP to Non-GAAP Measures (In thousands of U.S. dollars, except per share data)    
     
    Three  Months  Ended    
    May 31,     February 28,    
Non-GAAP Net Loss   2017     2017    
GAAP net loss attributable to SemiLEDs stockholders   $ (1,586 )   $ (1,142 )  
Adjustments:                  
Stock-based compensation expense     43       81    
Impairment loss related to cost method investment     352       —    
Income tax effect     —       —    
Non-GAAP net loss attributable to SemiLEDs stockholders   $ (1,191 )   $ (1,061 )  
Diluted net loss per share attributable to SemiLEDs stockholders:                  
GAAP net loss   $ (0.45 )   $ (0.32 )  
Non-GAAP net loss   $ (0.34 )   $ (0.30 )  
     
    Three  Months  Ended    
    May 31,     February 28,    
Free Cash Flow   2017     2017    
Net cash used in operating activities   $ (858 )   $ (638 )  
Less: Capital expenditures     61       20    
Total free cash flows   $ (919 )   $ (658 )  

Contacts: Christopher Lee Chief Financial Officer SemiLEDs Corporation +886-37-586788 investor@semileds.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 0

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 0

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 2

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 0

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 0

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 0

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading

Top 5 Most Recently Viewed Articles

Securiti Earns Noteworthy AWS Security Competency in AI

Updated Category News Views 375

Securiti Achieves AWS Security Competency Status in AI Security Securiti, the pioneer of the Data+AI Command Center, proudly announces its recent achievement of Amazon Web Services (AWS) Security Competency status in the innovative AI Security category. This new milestone highlights Securiti as one of the select inaugural partners recognized by AWS for its exceptional...

Continue Reading
Exciting Family Medicine Forum in Winnipeg This Fall

Updated Category News Views 204

Join the Family Medicine Forum in Winnipeg Mark your calendars, as the Family Medicine Forum is heading to Winnipeg this November for an enriching experience that promises to bring together family physicians from across the nation. This premier event is not only a chance to learn but to celebrate the vital work family doctors do every day. The Essence of Family Medicine...

Continue Reading
Man Group PLC Reveals Interest in Dowlais Group Securities

Updated Category News Views 106

Understanding the Disclosure by Man Group PLC In the realm of financial markets, disclosures play a crucial role in maintaining transparency and informing stakeholders about significant market movements. Recently, Man Group PLC made headlines by revealing its position regarding Dowlais Group PLC's relevant securities. This disclosure is essential as it reflects the...

Continue Reading
Experity Welcomes Bobby Ghoshal as New COO and President

Updated Category News Views 371

Experity Welcomes Bobby Ghoshal as President and COO Experity, a leader in on-demand healthcare solutions, has appointed Bobby Ghoshal as its new President and Chief Operating Officer. In this important role, Mr. Ghoshal will spearhead daily operations, steering the strategic direction for the company. His appointment is pivotal in enhancing Experity's mission to serve...

Continue Reading
LifeMD's Upcoming Engagements at Major Investor Conferences

Updated Category News Views 96

LifeMD's Upcoming Engagements at Major Investor Conferences LifeMD, Inc. (Nasdaq: LFMD), a trailblazer in virtual primary care, has recently announced its participation in several prominent investor conferences this September. As a company recognized for its innovative approach in telemedicine, LifeMD’s management is eager to showcase their vision and accomplishments to...

Continue Reading